ARS Investment Partners, LLC - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 173 filers reported holding ASCENDIS PHARMA A/S in Q2 2021. The put-call ratio across all filers is 4.45 and the average weighting 0.4%.

Quarter-by-quarter ownership
ARS Investment Partners, LLC ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q3 2023$26,773,362
+3.5%
285,918
-1.4%
3.32%
+9.8%
Q2 2023$25,870,005
+0.9%
289,860
+21.3%
3.02%
-1.8%
Q1 2023$25,629,654
-12.1%
239,038
+0.2%
3.08%
-20.6%
Q4 2022$29,142,783
+24.1%
238,621
+4.9%
3.88%
+20.1%
Q3 2022$23,484,000
+61.0%
227,427
+45.0%
3.23%
+62.0%
Q2 2022$14,585,000
-10.0%
156,900
+13.7%
1.99%
+27.6%
Q1 2022$16,199,000
-13.8%
138,030
-1.2%
1.56%
-9.5%
Q4 2021$18,790,000
-2.4%
139,673
+15.6%
1.73%
-10.4%
Q3 2021$19,256,000
+92.0%
120,810
+58.4%
1.93%
+88.6%
Q2 2021$10,031,000
+3.7%
76,252
+1.6%
1.02%
-9.1%
Q1 2021$9,675,000
-1.9%
75,068
+26.9%
1.12%
-7.4%
Q4 2020$9,863,000
+46.4%
59,136
+35.4%
1.21%
+14.6%
Q3 2020$6,739,000
+49.1%
43,669
+42.8%
1.06%
+24.4%
Q2 2020$4,521,000
+30.6%
30,571
-0.6%
0.85%
+1.8%
Q1 2020$3,463,000
+65.1%
30,748
+103.9%
0.84%
+136.8%
Q4 2019$2,098,00015,0790.35%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q2 2021
NameSharesValueWeighting ↓
RA Capital Management 5,865,338$978,221,00013.68%
Vivo Capital, LLC 1,797,745$299,828,00013.38%
Sofinnova Investments, Inc. 1,109,874$185,105,00011.02%
Avoro Capital Advisors LLC 1,800,000$300,204,0005.17%
Eventide Asset Management 1,704,148$284,218,0004.36%
Stenahm Asset Managment Ltd 29,000$4,837,0004.07%
Ghost Tree Capital, LLC 105,000$17,512,0003.90%
Eversept Partners, LP 187,043$31,195,0323.66%
Spyglass Capital Management LLC 701,594$117,012,0003.59%
Q Global Advisors, LLC 23,183$3,866,0002.72%
View complete list of ASCENDIS PHARMA A/S shareholders